Mona H. Allouba

Aswan, ASN, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Diagnosis and surgical treatment for a rare cause of arterial tortuosity.

Diagnosis and surgical treatment for a rare cause of arterial tortuosity.

Journal: JTCVS techniques

Published: May 30, 2025

Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathy.

Bi-allelic variants in POPDC2 cause an autosomal recessive syndrome presenting with cardiac conduction defects and hypertrophic cardiomyopathy.

Journal: American journal of human genetics

Published: August 18, 2024

Biallelic variants in POPDC2 cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathy.

Biallelic variants in POPDC2 cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathy.

Journal: medRxiv : the preprint server for health sciences

Published: July 15, 2024

The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.

The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.

Journal: American journal of human genetics

Published: March 15, 2023

Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.

Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies.

Journal: Nature cardiovascular research

Published: January 01, 2023

Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.

Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.

Journal: European heart journal

Published: October 25, 2022

New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy.

New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy.

Journal: Circulation

Published: August 30, 2021

An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.

An Investigation of Fibulin-2 in Hypertrophic Cardiomyopathy.

Journal: International journal of molecular sciences

Published: September 01, 2020

Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.

Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 27, 2020

Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions.

Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: June 20, 2020

The Egyptian Collaborative Cardiac Genomics (ECCO-GEN) Project: defining a healthy volunteer cohort.

The Egyptian Collaborative Cardiac Genomics (ECCO-GEN) Project: defining a healthy volunteer cohort.

Journal: NPJ genomic medicine

Published: September 18, 2019

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy.

Journal: Genome medicine

Published: November 26, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026